Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02983994

Enrollment

Registered

2016-12-06

Start date

2016-11-30

Completion date

2017-10-10

Last updated

2018-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, devices

Brief summary

The aim of the study is to evaluate the errors that may occur during inhalation of two devices in patients with asthma, as well as to study whether it relates to the degree of control of patient symptoms and the degree of compliance of medication symptoms. Finally, we also want to study the degree of patient satisfaction with each of the inhalers studied

Interventions

DEVICETURBUHALER®

DEVICESPIROMAX®

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of asthma with treatment indication with CI + LABA according to GINA 2015 guide and in dry powder device. * Over 18 years. * Patient in stable phase without having had exacerbations in the 3 months previous to the Inclusion in the study

Exclusion criteria

* Presence of relevant respiratory disease other than asthma (including COPD). * Refusal to participate in the study and sign informed consent or inability to To give informed consent. * Patients who have previously been treated with inhaled dust devices dry.

Design outcomes

Primary

Measure	Time frame	Description
The effectiveness of inhaler management.	two months	The effectiveness of inhaler management, It will be the comparison of the means of the number of errors detected between both devices.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026